Navidea Biopharmaceuticals Inc. (NAVB) Climbed 6.02% or 0.01 To Price $0.21 On Tuesday


Navidea Biopharmaceuticals Inc. (NAVB) climbed 6.02% or 0.01 to $0.21. It is about 289855 shares traded, which is 172.55% compare to the average total volume 167981. The market cap of NAVB is $34.73 million. The year to date change is -42.31%. The 52 week price range is from $0.2 to $0.68. Price of NAVB have changed -4.51% during last week. It have changed -15.08% over last month, -33.02% over last 3 months, -48.47% over last 6 months and -58.32% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NAVB is 0.23. It is 9.52% above current price. The 200-day Moving Averages for NAVB is 0.35. It is 66.67% above current price. The 52-week High is 0.68. It is 223.81% from the current price. The 52-week Low is 0.2. It is -4.76% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of NAVB is 35.01 on 2018-06-29. Short % to float is 3.52%. There are some statistics of NAVB. It is has market cap $34.73 million. The share outstanding is 162.96 million. The average volume is 167981. The percent of top 15 Institution holding is 7.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NAVB is -118.23%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NAVB is -61.58%.


Tags:

Share this post